Early SMA treatment safe, effective for preterm baby boy in Canada
For a boy with spinal muscular atrophy (SMA) who was born prematurely, treatment with Spinraza (nusinersen) until he…
Articles by Lindsey Shapiro, PhD
Zolgensma may improve infants’ nighttime breathing
Breathing disruptions during sleep, which were prevalent in infants with spinal muscular atrophy (SMA), tended to improve on…
Technique simplifies, accelerates newborn screening process
Researchers in Turkey have developed a new method for screening newborn blood samples for mutations associated with spinal muscular…
Economic burden shifting in US after arrival of SMA treatments
Children with spinal muscular atrophy (SMA) treated with Zolgensma (onasemnogene abeparvovec) used fewer healthcare resources and had lower…
More age-related health problems affect SMA patients earlier: Study
Adults with spinal muscular atrophy (SMA) experience more health problems affecting a range of bodily systems compared with the…
Spinraza led to motor gains for 3 SMA adults in small Japanese study
Spinraza (nusinersen) led to clinically meaningful motor improvements for three of six adults with spinal muscular atrophy (SMA)…
Evrysdi found safe, effective for SMA types 1-3 in new analysis
Note: This article was updated Sept. 25 to clarify that respiratory declines were observed in patients with SMA types…
Spinraza improves some aspects of sleep for children with SMA type 1
Treatment with Spinraza (nusinersen) improved certain aspects of sleep for children with spinal muscular atrophy (SMA) type 1,…
Newborn screening risk of false negatives highlighted in case report
Newborn screening might not be able to detect certain rare genetic mutations that cause spinal muscular atrophy (SMA), according…
Study finds how life quality changes over 1.5 years for SMA children
Children with spinal muscular atrophy (SMA) experience impaired health-related quality of life even when using disease-modifying therapies, according…